Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Capillary leak syndrome
ADR ID BADD_A00753
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.07      Oedema NEC
08.01.07.012      Capillary leak syndrome
24      Vascular disorders
24.06      Decreased and nonspecific blood pressure disorders and shock
24.06.03      Vascular hypotensive disorders
24.06.03.001      Capillary leak syndrome
Description A disorder characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure. [CTCAE] A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE. [MeSH]
MedDRA Code 10007196
MeSH ID D019559
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Capillary leak syndrome | Acute vascular leak syndrome | Capillary Leak Syndrome | Capillary Leak Syndromes | Clarkson Disease | Systemic Capillary Leak Syndrome | Clinical Capillary Leak Syndrome
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Angiopoietin-related protein 4Q9BY76T98635
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00036Acitretin--
BADD_D00076Allopurinol0.000034%
BADD_D00168Arsenic--
BADD_D00214Basiliximab--
BADD_D00269Bexarotene0.000139%
BADD_D00282Blinatumomab--
BADD_D00318Busulfan--
BADD_D00330Cabozantinib0.000533%
BADD_D00364Carboplatin0.000533%
BADD_D00367Carfilzomib0.000139%
BADD_D00407Cefuroxime0.000167%
BADD_D00495Clofarabine0.000347%
BADD_D00560Cytarabine0.000278%
BADD_D00561Cytarabine hydrochloride--
BADD_D00685Dinutuximab--
BADD_D00699Docetaxel0.000208%
BADD_D00854Etoposide0.000139%
BADD_D00858Everolimus0.000190%
BADD_D00931Fluorouracil0.001411%
BADD_D01009Gemcitabine0.002849%
BADD_D01010Gemcitabine hydrochloride--
BADD_D01133Ifosfamide--
BADD_D01136Imatinib0.000139%
BADD_D01142Imiquimod--
BADD_D01170Interferon beta-1b--
BADD_D01213Isotretinoin0.001263%
BADD_D01275Levofloxacin0.000045%
BADD_D01599Olanzapine0.000282%
BADD_D01620Oprelvekin--
BADD_D01653Paclitaxel0.001066%
The 1th Page    1 2    Next   Last    Total 2 Pages